Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Journal of Gastroenterology|January 23, 2009
Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patientsJohn S Moody, Stephen M Sawrie, Kevin R Kozak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinomaJames A Bonner, Eddy S Yang, Hoa Q Trummell, et al.
The Journal of Surgical Research|July 10, 2003
Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibodyZhi-qiang Huang, Donald J Buchsbaum, Kevin P Raisch, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2009
Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neckJimmy J Caudell, Philip E Schaner, Renee A Desmond, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Margin on gross tumor volume and risk of local recurrence in head-and-neck cancerJimmy J Caudell, Ruby F Meredith, Sharon A Spencer, et al.
Advances in Radiation Oncology|May 1, 2023
Biological Effective Radiation Dose for Multiple Myeloma PalliationRuby F Meredith, John R Bassler, Andrew M McDonald, et al.
Head & Neck|March 13, 2012
Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancerAleksandar F Dragovic, Jimmy J Caudell, Sharon A Spencer, et al.
Genes & Diseases|February 12, 2020
Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapiesHongxing Shen, Eddy Shih-Hsin Yang, Marty Conry, et al.
Head & Neck|October 13, 2011
Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancerAleksandar F Dragovic, James A Bonner, Sharon A Spencer, et al.
Seminars in Radiation Oncology|August 14, 2002
Epidermal growth factor receptor as a therapeutic target in head and neck cancerJames A Bonner, Jennifer De Los Santos, Harlan W Waksal, et al.
Pageof 12